ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - clomiphene citrate -

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - clomiphene citrate - tablet - 50 mg

كينيا - الإنجليزية - Pharmacy and Poisons Board

medcure healthcare ltd kensia house muranga road - clomiphene 50mg tablets - tablet - clomiphene citrate 50mg - clomifene

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - toremifene citrate, quantity: 88.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; povidone; maize starch - for the first line treatment of hormone-dependent metastatic breast cancer in postmenopausal women. it is not recommended for patients with oestrogen receptor negative tumours.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; croscarmellose sodium; maize starch; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tamoxifen citrate, quantity: 15.2 mg (equivalent: tamoxifen, qty 10 mg) - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; croscarmellose sodium; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

renable pharma limited - enclomifene citrate - hypogonadism - sex hormones and modulators of the genital system, - treatment of hypogonadotropic hypogonadism in men

الإمارات العربية المتحدة - الإنجليزية - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

clomifene citrate bp -

كينيا - الإنجليزية - Pharmacy and Poisons Board

national pharmacy ltd p.o box 17843-00500 nairobi, kenya - clomiphene citrate - tablet - 50mg - clomifene

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

n.v. organon - follitropin beta - infertility; hypogonadism - sex hormones and modulators of the genital system, - in the female:puregon is indicated for the treatment of female infertility in the following clinical situations:anovulation (including polycystic ovarian syndrome, pcos) in women who have been unresponsive to treatment with clomifene citrate;controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in-vitro fertilisation / embryo transfer (ivf/et), gamete intrafallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).in the male:deficient spermatogenesis due to hypogonadotrophic hypogonadism.